You have access
CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
TOSHIAKI HAGIWARA, KIICHI SUGIMOTO, HIROTAKA MOMOSE, TAKAHIRO IRIE, KUMPEI HONJO, YU OKAZAWA, MASAYA KAWAI, SHINGO KAWANO, SHINYA MUNAKATA, MAKOTO TAKAHASHI, YUTAKA KOJIMA, NOBUKO SERIZAWA, AKIHITO NAGAHARA, ROBERT M. HOFFMAN, MALCOLM V. BROCK and KAZUHIRO SAKAMOTO
Anticancer Research February 2022, 42 (2) 697-707; DOI: https://doi.org/10.21873/anticanres.15528
